Tachycardia, Supraventricular clinical trials

The registry lists 73 studies for Tachycardia, Supraventricular across more than 10 countries. 22 are recruiting or about to start. 39 of them are mainly about Tachycardia, Supraventricular (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.

Get an email when these change. Save the Tachycardia, Supraventricular studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 37
Recruiting: 14
Status unknown: 11
Not yet recruiting: 8
Withdrawn: 2
Terminated: 1

Phase

Phase 4: 7
Phase 3: 5
Phase 1: 2
Phase 2: 2

Where

United States: 18
Canada: 8
United Kingdom: 5
China: 5
Germany: 4
Spain: 4

Who runs them

Assiut University (3) · Corxel Pharmaceuticals (2) · Edgar Jaeggi (2) · Acutus Medical (2) · Stereotaxis (2) · Bardy Diagnostics, Inc. (2) · Yonsei University (2) · Insel Gruppe AG, University Hospital Bern (2)

What is being tested here

Drugs under test in Tachycardia, Supraventricular studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Adenosine	2	1	6
Diltiazem	1	0	2
Dexmedetomidine	0	0	2
Etripamil	0	0	1
Digoxin	0	1	1
Propranolol	0	1	1
Caffeine	0	0	1
Midazolam	0	0	1

Drug classes tested here Calcium channel blockers 1 open

Coming up

1phase 3 study under way

7studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7

Dec 2026Validity and Algorithm Development for Detection of Supraventricular Tachycardia in Children-A Clinical Pilot Study · University of Turku
Dec 2026Localization of Anatomical Structures Involved in Nodal Tachycardias by High Density Mapping. · University Hospital, Toulouse
Mar 2027Head-to-Head (H2H) Comparison of Ambulatory Cardiac ECG Monitors in Japan · iRhythm Technologies, Inc.
May 2027NASVAL-SVT: Nasal Swab Versus Modified Valsalva for Supraventricular Tachycardia · Marmara University Pendik Training and Research Hospital
Jun 2027PERceptions of Diltiazem Versus ADEnosine for Treatment of Supraventricular Tachycardia in the Emergency Department · University of Iowa
Jul 2027Adenosine vs Diltiazem for Treatment of SVT in the ED · Anne E. Zepeski
Sep 2027Cardiac Arrhythmias in Pediatric Emergency Department · Assiut University

Who these studies take

Of the 14 Tachycardia, Supraventricular studies recruiting now, 8 (57%) set no upper age limit and 2 (14%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (14%) take healthy volunteers.

Recruiting studies that take each age, of 14
Age	Women	Men
10	0 (0%)	0 (0%)
18	14 (100%)	14 (100%)
30	14 (100%)	14 (100%)
40	14 (100%)	14 (100%)
50	14 (100%)	14 (100%)
65	14 (100%)	14 (100%)
75	12 (86%)	12 (86%)
85	11 (79%)	11 (79%)

Across all 73 studies, recruiting or not: 32% stop at 75 or younger and 23% at 65; 32% take children; 3% are for women only and 3% for men only; 10% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Tachycardia, Supraventricular studies take

Of 18 interventional studies with no phase under Tachycardia, Supraventricular, half reached primary completion within 26 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Interventional, no phase	26 mo9–48 · 18 studies	—	—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Results posted1

Comparison of Single-syringe vs. Double-syringe Techniques for Adenosine Administration in PSVTNov 6, 2026NCT07554170

Studies

Recruiting first, then most recently updated. Showing 50 of 73. Browse all 73 → or search them.